Superintendent Olympia Della Flora Shares Insights on How to Best Help Students in Latest Episode of Change Starts Here

Marion, Ohio – Being an educator is a challenging and rewarding job, and nobody knows that better than Olympia Della Flora, the current superintendent for Marion City Schools in Ohio. In a recent episode of the podcast Change Starts Here, host Dustin Odham sat down with Della Flora to discuss her experience as an educator, from teacher to principal to superintendent, and her insights on how to best help students.

Growing up with an elementary school mother and a bus-driving father, Della Flora never intended to get into education. But after earning her Bachelor’s degree in Biology, she pursued a Master’s in Education and discovered her passion for helping students succeed. Her experience has taught her to build relationships with students to learn as much as possible about each one, even when it means going beyond the curriculum.

During the interview, Della Flora shared her strategies for creating a safe and supportive environment for students, including taking pieces of a student’s life and using them to create a story that helps teachers better understand how to address them in the classroom. She also emphasized the importance of knowing students’ triggers and how they learn best.

“I think it’s sometimes difficult for teachers because they have their schedules, and, you know, they need to get through their lessons, they have their curriculum, that they need to hit certain benchmarks,” said Della Flora. “But sometimes we get caught up in that, and we forget that we have little people that are sitting in our classrooms every single day.”

Della Flora’s insights are a valuable resource for educators who are looking to create a positive and supportive learning environment for their students. By taking the time to get to know each student as an individual, educators can build stronger relationships, better address their unique needs, and help them reach their full potential.

The Change Starts Here podcast is available on all major podcast platforms. For more information, visit the show’s website.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More